School of Medicine
Showing 41-50 of 170 Results
-
Jenny Deng
Clinical Research Coordinator Associate, Dermatology
BioJenny Deng is an Assistant Clinical Research Coordinator for Dr. Jean Tang in the Dermatology department. She received her bachelor’s in science from the University of California, Santa Cruz with a major in Molecular and Cell Developmental Biology. She is also a certified phlebotomy technician with an active license. Jenny was born and raised in San Francisco, and when she is not working, enjoys her spare time traveling, working out, and exploring new restaurants to eat.
-
Meghan Dickman, MD
Clinical Associate Professor, Dermatology
BioMeghan Dickman, M.D., is Clinical Associate Professor of Dermatology and Medical Director of Dermatology at Stanford Health Care Tri-Valley. Dr. Dickman earned her B.S., with distinction, from the University of Michigan in 2006. She received her medical degree from the University of California, San Francisco. During medical school, Dr. Dickman was inducted into the Alpha Omega Alpha Honor Medical Society. She completed her dermatology residency at Stanford University and served as Chief Resident in her final year. She is board certified in dermatology by the American Board of Dermatology. Her professional focus is general medical dermatology, including acne, psoriasis, skin cancer, and dermatologic surgery.
Dr. Dickman also serves as the Medical Director of Dermatology for Stanford Health Care Tri-Valley and the Director of the East Bay Clinical Network for Stanford Dermatology, leading the department of dermatology's program building efforts and clinical operations in the East Bay region of the San Francisco Bay Area. -
David Fiorentino, MD, PhD
Professor of Dermatology
On Partial Leave from 04/01/2026 To 04/30/2026Current Research and Scholarly InterestsFrom a clinical standpoint, I am particularly focused in the care of patients with myositis or systemic sclerosis. We offer clinical trials, including novel, cutting-edge cellular-based (e.g. chimeric antigen receptor, or, CAR T) therapies for these diseases. We are particularly interested in understanding the role of auto antigens in providing windows into disease pathogenesis, as well as their potential direct role of autoantibodies in causing disease.
